Lantheus Holdings Inc. (LNTH) Shares Up 7.3%
Lantheus Holdings Inc. (NASDAQ:LNTH) shares traded up 7.3% during mid-day trading on Friday . The company traded as high as $4.80 and last traded at $4.70, with a volume of 188,832 shares. The stock had previously closed at $4.38.
A number of research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Lantheus Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, March 30th. Jefferies Group reaffirmed a “buy” rating on shares of Lantheus Holdings in a report on Wednesday, May 4th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of Lantheus Holdings in a report on Monday, April 11th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $5.55.
The stock’s market capitalization is $152.17 million. The firm has a 50 day moving average of $2.91 and a 200 day moving average of $2.40.
Lantheus Holdings (NASDAQ:LNTH) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.28. The company earned $76.50 million during the quarter, compared to the consensus estimate of $72.43 million. Equities analysts anticipate that Lantheus Holdings Inc. will post $0.35 earnings per share for the current fiscal year.
A hedge fund recently raised its stake in Lantheus Holdings stock. Numeric Investors LLC boosted its position in shares of Lantheus Holdings Inc. (NASDAQ:LNTH) by 42.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 525,258 shares of the company’s stock after buying an additional 156,084 shares during the period. Numeric Investors LLC owned 1.67% of Lantheus Holdings worth $1,775,000 as of its most recent SEC filing.
Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.